Janet Tu

6PUBLICATIONS
65CO-AUTHORS
Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).

Xiuning Le, Jyoti D Patel, Elaine Shum

|May 02, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.

Mehmet Altan, Janet Tu, Denái R Milton

|Apr 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.

Sang T Kim, Yanshuo Chu, Mercy Misoi

Pageof 1

Frequent Collaborators

4 joint publications

Don L Gibbons

4 joint publications

Tina Cascone

3 joint publications

Aung Naing

2 joint publications

Sang T Kim